Abbott Laboratories's total assets for Q2 2026 were $109.22B, a decrease of -1.10% from the previous quarter. DE:ABL total liabilities were $57.45B for the fiscal quarter, a -0.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.